Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alexander Goldman

Showing results (1-10 of 3) with videos related to

Pageof 1
Sort By:
The Israel Medical Association Journal : IMAJ|June 22, 2021
Circulating Endothelial Progenitor Cells in Patients with Heart Failure with Preserved versus Reduced Ejection FractionYana Kakzanov, Ziv Sevilya, Mordehay Veturi, et al.
Journal of Cardiovascular Pharmacology|June 26, 2024
The Effect of SGLT2 Inhibitor Therapy on Endothelial Progenitor Cell Function in Patients With Heart FailureYana Kakzanov, Ziv Sevilya, Alexander Goldman, et al.
Annals of Neurology|July 17, 2016
Truncating mutations in APP cause a distinct neurological phenotypeSteven Klein, Alexander Goldman, Hane Lee, et al.
Pageof 1

Showing results (1-10 of 3) with videos related to

Sort By:
Pageof 1
The Israel Medical Association Journal : IMAJ|June 22, 2021
Circulating Endothelial Progenitor Cells in Patients with Heart Failure with Preserved versus Reduced Ejection FractionYana Kakzanov, Ziv Sevilya, Mordehay Veturi, et al.
Journal of Cardiovascular Pharmacology|June 26, 2024
The Effect of SGLT2 Inhibitor Therapy on Endothelial Progenitor Cell Function in Patients With Heart FailureYana Kakzanov, Ziv Sevilya, Alexander Goldman, et al.
Annals of Neurology|July 17, 2016
Truncating mutations in APP cause a distinct neurological phenotypeSteven Klein, Alexander Goldman, Hane Lee, et al.
Pageof 1